Long-term efficacy and safety of prophylaxis with rFVIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) study.

CONCLUSION: Prophylaxis with rFVIII reduced bleeding and number of target joints, even with low-dose regimen in Chinese pediatric patients with HA. Other than the efficacy and safety, factors such as poor disease control, improved economic stability and stable financial support made prophylaxis as an attractive treatment option. PMID: 28326849 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28326849?dopt=Abstract

Source: Current Medical Research and Opinion - March 24, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research